InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

QIAGEN N.V.

QGEN Clue Score55
Netherlands Fiscal year ends December CIK 0001015820
$45.38 +1.91% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $45.38 −10.63% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1,338.0Operating income98.8Net income80.4EPS, diluted0.34Fiscal year 2017Revenue1,417.5 +5.9%Operating income153.4Net income40.4 −49.8%EPS, diluted0.17 −50.0%Fiscal year 2018Revenue1,501.8 +5.9%Operating income266.6Net income190.4 +371.3%EPS, diluted0.82 +382.4%Fiscal year 2019Revenue1,526.4 +1.6%Operating income−26.1Net income−41.5 −121.8%EPS, diluted−0.18 −122.0%Fiscal year 2020Revenue1,870.3 +22.5%Operating income386.4Net income359.2EPS, diluted1.53Fiscal year 2021Revenue2,251.7 +20.4%Operating income630.1Net income512.6 +42.7%EPS, diluted2.21 +44.4%Fiscal year 2022Revenue2,141.5 −4.9%Operating income531.5Net income423.2 −17.4%EPS, diluted1.84 −16.7%Fiscal year 2023Revenue1,965.3 −8.2%Operating income409.9Net income341.3 −19.4%EPS, diluted1.48 −19.6%Fiscal year 2024Revenue1,978.2 +0.7%Operating income97.7Net income83.6 −75.5%EPS, diluted0.37 −75.0%Fiscal year 2025Revenue2,090.0 +5.7%Operating income465.9Net income424.9 +408.3%EPS, diluted1.94 +424.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1,338.0 1,417.5 1,501.8 1,526.4 1,870.3 2,251.7 2,141.5 1,965.3 1,978.2 2,090.0
Growth +5.9% +5.9% +1.6% +22.5% +20.4% −4.9% −8.2% +0.7% +5.7%
Operating income 98.8 153.4 266.6 −26.1 386.4 630.1 531.5 409.9 97.7 465.9
Net income 80.4 40.4 190.4 −41.5 359.2 512.6 423.2 341.3 83.6 424.9
Growth −49.8% +371.3% −121.8% +42.7% −17.4% −19.4% −75.5% +408.3%
EPS, diluted 0.34 0.17 0.82 −0.18 1.53 2.21 1.84 1.48 0.37 1.94
Growth −50.0% +382.4% −122.0% +44.4% −16.7% −19.6% −75.0% +424.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin63.1%Operating margin7.4%Net margin6.0%Free cash flow margin20.0%Fiscal year 2017Gross margin65.1%Operating margin10.8%Net margin2.8%Free cash flow margin13.9%Fiscal year 2018Gross margin66.6%Operating margin17.8%Net margin12.7%Free cash flow margin16.6%Fiscal year 2019Gross margin65.9%Operating margin−1.7%Net margin−2.7%Free cash flow margin13.9%Fiscal year 2020Gross margin65.9%Operating margin20.7%Net margin19.2%Free cash flow margin17.4%Fiscal year 2021Gross margin64.4%Operating margin28.0%Net margin22.8%Free cash flow margin19.9%Fiscal year 2022Gross margin64.7%Operating margin24.8%Net margin19.8%Free cash flow margin27.4%Fiscal year 2023Gross margin62.8%Operating margin20.9%Net margin17.4%Free cash flow margin15.8%Fiscal year 2024Gross margin48.9%Operating margin4.9%Net margin4.2%Free cash flow margin25.6%Fiscal year 2025Gross margin62.2%Operating margin22.3%Net margin20.3%Free cash flow margin21.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 63.1% 65.1% 66.6% 65.9% 65.9% 64.4% 64.7% 62.8% 48.9% 62.2%
Operating margin 7.4% 10.8% 17.8% −1.7% 20.7% 28.0% 24.8% 20.9% 4.9% 22.3%
Net margin 6.0% 2.8% 12.7% −2.7% 19.2% 22.8% 19.8% 17.4% 4.2% 20.3%
Free cash flow margin 20.0% 13.9% 16.6% 13.9% 17.4% 19.9% 27.4% 15.8% 25.6% 21.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow341.6Capital expenditure−74.5Free cash flow267.1Buybacks0.0Fiscal year 2017Operating cash flow286.8Capital expenditure−90.1Free cash flow196.7 −26.3%Buybacks−61.0Fiscal year 2018Operating cash flow359.5Capital expenditure−109.8Free cash flow249.7 +27.0%Buybacks−104.7Fiscal year 2019Operating cash flow330.8Capital expenditure−118.0Free cash flow212.9 −14.7%Buybacks−74.5Fiscal year 2020Operating cash flow457.8Capital expenditure−132.8Free cash flow325.0 +52.7%Buybacks−64.0Fiscal year 2021Operating cash flow639.0Capital expenditure−189.9Free cash flow449.1 +38.2%Buybacks−100.0Fiscal year 2022Operating cash flow715.3Capital expenditure−129.2Free cash flow586.0 +30.5%Buybacks0.0Fiscal year 2023Operating cash flow459.5Capital expenditure−149.7Free cash flow309.7 −47.1%Buybacks0.0Dividends paid0.0Fiscal year 2024Operating cash flow673.6Capital expenditure−167.2Free cash flow506.4 +63.5%Buybacks−292.1Dividends paid0.0Fiscal year 2025Operating cash flow654.3Capital expenditure−201.0Free cash flow453.3 −10.5%Buybacks−280.1Dividends paid−54.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 341.6 286.8 359.5 330.8 457.8 639.0 715.3 459.5 673.6 654.3
Capital expenditure −74.5 −90.1 −109.8 −118.0 −132.8 −189.9 −129.2 −149.7 −167.2 −201.0
Free cash flow 267.1 196.7 249.7 212.9 325.0 449.1 586.0 309.7 506.4 453.3
Growth −26.3% +27.0% −14.7% +52.7% +38.2% +30.5% −47.1% +63.5% −10.5%
Buybacks 0.0 −61.0 −104.7 −74.5 −64.0 −100.0 0.0 0.0 −292.1 −280.1
Dividends paid n/a n/a n/a n/a n/a n/a n/a 0.0 0.0 −54.2

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash439.2Total debt1,067.1Net cash (debt)−627.9Shareholders’ equity2,607.1Debt to equity0.41Fiscal year 2017Cash657.7Total debt1,758.3Net cash (debt)−1,100.5Shareholders’ equity2,541.0Debt to equity0.69Fiscal year 2018Cash1,159.1Total debt2,174.2Net cash (debt)−1,015.1Shareholders’ equity2,635.0Debt to equity0.83Fiscal year 2019Cash623.6Total debt1,706.4Net cash (debt)−1,082.7Shareholders’ equity2,536.6Debt to equity0.67Fiscal year 2020Cash598.0Total debt1,922.7Net cash (debt)−1,324.8Shareholders’ equity2,797.8Debt to equity0.69Fiscal year 2021Cash880.5Total debt1,941.8Net cash (debt)−1,061.3Shareholders’ equity3,096.6Debt to equity0.63Fiscal year 2022Cash730.7Total debt1,861.5Net cash (debt)−1,130.8Shareholders’ equity3,466.6Debt to equity0.54Fiscal year 2023Cash668.1Total debt1,509.8Net cash (debt)−841.7Shareholders’ equity3,807.8Debt to equity0.40Fiscal year 2024Cash663.6Total debt1,391.5Net cash (debt)−728.0Shareholders’ equity3,567.3Debt to equity0.39Fiscal year 2025Cash839.0Total debt1,654.4Net cash (debt)−815.4Shareholders’ equity3,778.2Debt to equity0.44
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 439.2 657.7 1,159.1 623.6 598.0 880.5 730.7 668.1 663.6 839.0
Total debt 1,067.1 1,758.3 2,174.2 1,706.4 1,922.7 1,941.8 1,861.5 1,509.8 1,391.5 1,654.4
Net cash (debt) −627.9 −1,100.5 −1,015.1 −1,082.7 −1,324.8 −1,061.3 −1,130.8 −841.7 −728.0 −815.4
Shareholders’ equity 2,607.1 2,541.0 2,635.0 2,536.6 2,797.8 3,096.6 3,466.6 3,807.8 3,567.3 3,778.2
Debt to equity 0.41 0.69 0.83 0.67 0.69 0.63 0.54 0.40 0.39 0.44

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1,338.0 1,417.5 1,501.8 1,526.4 1,870.3 2,251.7 2,141.5 1,965.3 1,978.2 2,090.0
Growth +5.9% +5.9% +1.6% +22.5% +20.4% −4.9% −8.2% +0.7% +5.7%
493.3 495.0 500.9 521.2 637.6 800.8 757.0 731.6 1,010.9 790.5
844.7 922.6 1,001.0 1,005.3 1,232.7 1,450.8 1,384.6 1,233.7 967.4 1,299.5
Growth +9.2% +8.5% +0.4% +22.6% +17.7% −4.6% −10.9% −21.6% +34.3%
n/a 102.1 104.6 112.3 111.7 128.1 129.7 119.3 113.4 125.7
98.8 153.4 266.6 −26.1 386.4 630.1 531.5 409.9 97.7 465.9
Growth +55.2% +73.8% −109.8% +63.1% −15.7% −22.9% −76.2% +376.8%
56.9 114.4 225.7 −77.8 439.5 625.8 512.6 429.8 121.1 490.3
−23.4 74.0 35.4 −36.3 80.3 113.2 89.4 88.5 37.6 65.4
80.4 40.4 190.4 −41.5 359.2 512.6 423.2 341.3 83.6 424.9
Growth −49.8% +371.3% −121.8% +42.7% −17.4% −19.4% −75.5% +408.3%
Per share
0.34 0.18 0.84 −0.18 1.57 2.25 1.86 1.50 0.38 1.96
0.34 0.17 0.82 −0.18 1.53 2.21 1.84 1.48 0.37 1.94
Growth −50.0% +382.4% −122.0% +44.4% −16.7% −19.6% −75.0% +424.3%
234.8 228.1 226.6 226.8 228.4 228.0 227.6 228.1 222.6 217.2
239.0 233.0 233.5 226.8 234.2 232.0 230.1 230.6 224.7 218.9
Growth −2.5% +0.2% −2.9% +3.3% −0.9% −0.8% +0.2% −2.6% −2.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 2.2% a year over five years, and earnings per share grew 4.9% a year.
  • The diluted share count fell 6.5% in five years, so buybacks did some of the work per share.
  • Operating margin is up 1.6 points on five years ago, at 22.3%.
  • A net loss in 1 of 10 years on file.